|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-23-2004
NEW YORK (Reuters Health) - Pregnant women who regularly work the night shift may have an increased risk of a miscarriage late in pregnancy or a stillbirth, a new study suggests.
BOSTON (Reuters) - Regular exercise is not enough to offset the health problems associated with obesity -- but that shouldn't stop people who are overweight from working out, according to a study to be published in Thursday's New England Journal of Medicine.
NEW YORK (Reuters Health) - The results of a new study confirm that using the contraceptive Depo-Provera is associated with bone loss.
NEW YORK (Reuters Health) - Sales of pregnancy tests typically soar in the first months of the year, as more women than usual tend to become pregnant -- or just think they are, according to Inverness Medical, the makers of the Clearblue Easy pregnancy tests.
NEW YORK (Reuters Health) - Gastric bypass surgery and similar operations for severe obesity lead to long-term weight loss, and people who have undergone such a procedure have lower risks for heart disease and diabetes than conventionally treated individuals, according to a new Swedish study.
NEW YORK (Reuters Health) - After being diagnosed with prostate cancer, men are capable of adhering to a low-fat diet for at least a year if they receive good counseling and support, a new study shows.
AMSTERDAM (Reuters) - Two of the world's top mobile phone makers said more research is needed into the potential for cell phone radiation to damage DNA, following a laboratory study by 12 European institutes which found harmful effects.
NEW YORK (Reuters Health) - Many people with diabetes find that they become mentally and physically sluggish during periods when their blood sugar level rises in the course of their daily routines, investigators report.
NEW YORK (Reuters) - Adolor Corp. said on Thursday its experimental treatment for post-operative bowel obstruction did not confer a significant benefit in a late-stage clinical trial in Europe, sending its stock skidding.
NEW YORK (Reuters Health) - Daily aspirin is usually recommended for people at increased risk for heart disease, and people with diabetes come into that category. While the proportion of diabetic patients who take aspirin has increased in recent years in the US, new research indicates that some are still not doing so.
|
|
